Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Ratios

Advanced Flower Capital (AFCG) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for Advanced Flower Capital (AFCG) over the last 4 years, with Q3 2025 value amounting to $2.6 million.

  • Advanced Flower Capital's Change in Accured Expenses rose 23543.92% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 15583.27%. This contributed to the annual value of -$1.5 million for FY2024, which is 26653.59% down from last year.
  • Latest data reveals that Advanced Flower Capital reported Change in Accured Expenses of $2.6 million as of Q3 2025, which was up 23543.92% from -$2.7 million recorded in Q2 2025.
  • Advanced Flower Capital's Change in Accured Expenses' 5-year high stood at $2.6 million during Q3 2025, with a 5-year trough of -$2.7 million in Q2 2025.
  • For the 4-year period, Advanced Flower Capital's Change in Accured Expenses averaged around $27626.6, with its median value being $25470.0 (2022).
  • Examining YoY changes over the last 5 years, Advanced Flower Capital's Change in Accured Expenses showed a top increase of 669649.0% in 2023 and a maximum decrease of 442591.21% in 2023.
  • Over the past 4 years, Advanced Flower Capital's Change in Accured Expenses (Quarter) stood at -$335303.0 in 2022, then plummeted by 362.3% to -$1.6 million in 2023, then soared by 161.32% to $950461.0 in 2024, then skyrocketed by 169.04% to $2.6 million in 2025.
  • Its Change in Accured Expenses was $2.6 million in Q3 2025, compared to -$2.7 million in Q2 2025 and $1.4 million in Q1 2025.